<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03401242</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0190</org_study_id>
    <nct_id>NCT03401242</nct_id>
  </id_info>
  <brief_title>Prevalence of ESBL and CPE in French Nursing Homes</brief_title>
  <acronym>CARBEHPAD</acronym>
  <official_title>Investigation of the Prevalence of Fecal Carriage of Extended Spectrum bêta-lactamase Producing Enterobacteriaceae (ESBL) and Carbapenemase Producing Enterobacteriaceae (CPE) in Nursing Homes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CARBEHPAD is a multicentric randomized prevalence study aiming to assess the frequency of
      Enterobacteriaceae (ESLB) and carbapenemase producing Enterobacteriaceae (CPE) carriage in
      Pays de la Loire nursing homes.

      A sample of 50 nursing homes (NH) in Pays de la Loire will be randomly selected for
      inclusion, and a sample of 1/3 of residents of these NH will be screened for ESBL and/or CPE
      fecal carriage. Epidemiological data on each resident will be collected to identify risk
      factors for such carriage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Pays de la Loire region is impacted by 2 main CPE outbreaks in the 2 major university
      hospitals in this region. A sample of 50 nursing homes (NH) in Pays de la Loire region
      (France) will be randomly selected for inclusion in CARBEHPAD study. NH directors will be
      contacted for agreement for inclusion in CARBEHPAD study. In each of the included NH, a
      sample of one third of residents will be randomly selected for inclusion. Upon agreement,
      each resident included will be screened through endorectal swabbing for ESBL and/or CPE
      carriage.

      Epidemiological data will be collected for each resident regarding demographic data, risk
      factors for ESBL and/or CPE carriage, comorbidities. These data collected in the NH will be
      completed with data collection from national NH database regarding: previous hospitalization,
      treatments (including antibiotics), surgery.

      Data on infection control and prevention will be collected in each NH to assess cross
      transmission of resistant bacteria in these settings.

      Comparison of isolated strains will be performed to assess clonal dissemination of these
      resistant Enterobacteriaceae in NH. Data regarding infection control and prevention in each
      included NH will be collected aswell.

      An ESBL/CPE carrier status has no impact on medical care in NH regarding French
      recommendations on management of such resistant microorganisms.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>carbapenemase producing Enterobacteriaceae (CPE) carriage</measure>
    <time_frame>six months</time_frame>
    <description>Assessment of CPE carriage through endorectal swabbing.</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Enterobacteriaceae Infections</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      faecal samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1000 residents of the nursing homes of the 5 departments of Pays de la Loire will be
        included in this study protocol.

        Participants in the study will be randomly sampled according to a two-stage sampling
        design.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident present in the nursing home on the day of the survey.

          -  Resident having agreed to be included in the study.

          -  Resident with a social security number.

        Exclusion Criteria:

        - Resident non-compliant with sampling protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriel BIRGAND, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel BIRGAND, Dr</last_name>
    <phone>06 12 87 26 54</phone>
    <email>gabriel.birgand@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clément LEGEAY</last_name>
    <phone>02 41 35 59 34</phone>
    <email>clement.legeay@chu-angers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clément LEGEAY, Dr</last_name>
      <phone>02 41 35 59 34</phone>
      <email>Clement.legeay@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Clément LEGEAY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Challans Hospital</name>
      <address>
        <city>Challans</city>
        <zip>85302</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roselyne HUE, Dr</last_name>
      <phone>02 51 49 60 96</phone>
      <email>r.hue@ch-lvo.fr</email>
    </contact>
    <investigator>
      <last_name>Roselyne HUE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vendée Hospital</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvana COUTANT, Dr</last_name>
      <phone>02 51 44 63 29</phone>
      <email>Sylvana.coutant@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Sylvana COUTANT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Le Mans Hospital</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Céline CORROLER-BEC, Dr</last_name>
      <phone>02 43 43 28 09</phone>
      <email>ccorollerbec@ch-lemans.fr</email>
    </contact>
    <investigator>
      <last_name>Céline CORROLER-BEC, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabriel BIRGAND, Dr</last_name>
      <phone>02 40 08 39 86</phone>
      <email>Gabriel.birgand@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Gabriel BIRGAND, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Nazaire Hospital</name>
      <address>
        <city>Saint Nazaire</city>
        <zip>44606</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoit LIBEAU, Dr</last_name>
      <phone>02 72 27 85 37</phone>
      <email>b.libeau@chsaintnazaire.fr</email>
    </contact>
    <investigator>
      <last_name>Benoit LIBEAU, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saumur Hospital</name>
      <address>
        <city>Saumur</city>
        <zip>49400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stéphanie PERRON, Dr</last_name>
      <phone>02 41 53 35 73</phone>
      <email>sperron@ch-saumur.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphanie PERRON, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2018</study_first_submitted>
  <study_first_submitted_qc>January 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>January 15, 2018</last_update_submitted>
  <last_update_submitted_qc>January 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Carbapenemase</keyword>
  <keyword>Enterobacteriaceae</keyword>
  <keyword>extended spectrum beta-lactamases</keyword>
  <keyword>nursing homes</keyword>
  <keyword>prevalence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterobacteriaceae Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

